Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.41 |
| ▸ | FDPS | P14324 | 9/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27906995 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL3630817 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL28021411 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL28075094 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL3634312 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL5070252 | 0.94 | TSHR (0.39) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL8687541 | 0.94 | TSHR (0.53) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL8686371 | 0.94 | TSHR (0.53) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL8684913 | 0.94 | TSHR (0.53) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL8690214 | 0.94 | TSHR (0.53) | TSHRTHRBGGPS1FDPSSMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109528686-A | Utilize the polymer-lipid mixing nano particle of microring array and the capecitabine of capecitabine amphipathic characteristic | 杭州景杰生物科技有限公司 | 2019-03-29 | — | — | CN | claimed |
| CN-101252940-A | External composition for improving skin diseases comprising adenosyl cobalamin | KOREA RES INST CHEM TECH (KR) | 2008-08-27 | — | — | CN | claimed |
| CN-105658243-B | Ultrasound mediated drug delivery | 菲尼克斯解决方案有限公司 | 2019-11-08 | — | — | CN | disclosed |
| CN-110352071-A | Lipidic nanoparticles mRNA vaccine | 库瑞瓦格股份公司 | 2019-10-18 | — | — | CN | disclosed |
| CN-105163720-B | Remote loading sparingly water-soluble drug is to liposome | 佐尼奥尼制药股份有限公司 | 2019-10-11 | — | — | CN | disclosed |
| CN-105873568-B | Tool for lung specificity delivering | 赛伦斯治疗有限公司 | 2019-10-08 | — | — | CN | disclosed |
| CN-110302162-A | Modularization particle for immunotherapy | 耶鲁大学 | 2019-10-08 | — | — | CN | disclosed |
| CN-110251463-A | Lotion containing hormone | 贝朗医疗有限公司 | 2019-09-20 | — | — | CN | disclosed |
| CN-105848649-B | modular particles for immunotherapy | 耶鲁大学 | 2019-08-02 | — | — | CN | disclosed |
| CN-110003030-A | Trialkyl cation lipid and its application method | 野草莓树生物制药公司 | 2019-07-12 | — | — | CN | disclosed |
| CN-109922808-A | Liposome formulations for the treatment of cancer | 法国施维雅药厂 | 2019-06-21 | — | — | CN | disclosed |
| CN-101291678-A | Carrier composition for nucleic acid transfer | OTSUKA PHARMA CO LTD (JP) | 2008-10-22 | — | — | CN | disclosed |
| CN-101252940-A | External composition for improving skin diseases comprising adenosyl cobalamin | KOREA RES INST CHEM TECH (KR) | 2008-08-27 | — | — | CN | disclosed |
| CN-1915968-A | Neutral-cationic lipid for nucleic acid and drug delivery | ALZA CORP (US) | 2007-02-21 | — | — | CN | disclosed |
| CN-1732960-A | As suppressing the HIV-1 trans-activator combines usefulness with the trans-activating response sequence RNA phosphatidyl ethanolamine liposome | CHINESE ACAD INST CHEMISTRY (CN) | 2006-02-15 | — | — | CN | disclosed |
| CN-1387505-A | Compositions contg. hydroxyeicosatetraenoic acid derivs, and methods of use in treating dry eye disorders | ALCON UNIVERSAL LTD (CH) | 2002-12-25 | — | — | CN | disclosed |
| CN-1387502-A | 15-hydroxyeicosatetraenoic acid-related compounds and methods of use | ALCON UNIVERSAL LTD (CH) | 2002-12-25 | — | — | CN | disclosed |
| CN-1387435-A | Lipoxin A for the treatment of dry eye4And derivatives thereof | ALCON UNIVERSAL LTD (CH) | 2002-12-25 | — | — | CN | disclosed |
| CN-1382046-A | Heteroatom-inserted analogs of 15-hydroxyeicosatetraenoic acid and methods of use | ALCON UNIVERSAL LTD (CH) | 2002-11-27 | — | — | CN | disclosed |
| CN-1378536-A | Neutral-cationic lipids for nucleic acid and drug delivery | ALZA CORP (US) | 2002-11-06 | — | — | CN | disclosed |